Introduction: Dorsal augmentation (DA) rhinoplasty aims to restore or enhance the nasal dorsum’s aesthetic contour and structural integrity, often necessitating the use of graft materials. A wide array of graft options – including autologous, allogenic and alloplastic materials - have been developed, each with unique advantages and limitations. Aim: This review aims to critically evaluate the current literature on graft materials used for dorsal augmentation rhinoplasty – focusing on selection, long-term outcomes, and complications associated with each material. Methods: A PubMed search was performed using the terms “dorsal augmentation rhinoplasty,” and “grafts used for rhinoplasty”. Publication dates from 1957 – 2024 were included. Studies included encompassed the use of autologous, allogenic and alloplastic graft materials. Data was extracted to examine materials used, surgical approaches and reported post-operative outcomes. Results: Autologous cartilage grafts (septal, auricular, and costal) remains the most frequently utilized due to its superior biocompatibility profile and low infection risk. Donor-site morbidity and potential warping are notable associated issues. Allogenic materials (irradiated cartilage and acellular dermal matrices), offer reduced operative time but are associated with variable resorption rates and potential immune reactions. Alloplastic implants provide predictable initial cosmetic outcomes. However, they carry much higher risks of extrusion, infection and potential long-term instability. Conclusion: No single graft material is universally ideal for DA rhinoplasty. Optimal graft choice depends on individual patient anatomy, defect severity, long-term aesthetic goals and surgeon experience. This review highlights the ongoing innovation in tissue engineering and its promising role in improving long-term aesthetic and functional outcomes in DA rhinoplasty.